100 related articles for article (PubMed ID: 16019509)
1. Survivin expression in the progression of chronic myeloid leukemia: a sequential study in 16 patients.
Hernández-Boluda JC; Bellosillo B; Vela MC; Colomer D; Alvarez-Larrán A; Cervantes F
Leuk Lymphoma; 2005 May; 46(5):717-22. PubMed ID: 16019509
[TBL] [Abstract][Full Text] [Related]
2. Expression of the antiapoptotic gene survivin in chronic myeloid leukemia.
Badran A; Yoshida A; Wano Y; Imamura S; Kawai Y; Tsutani H; Inuzuka M; Ueda T
Anticancer Res; 2003; 23(1B):589-92. PubMed ID: 12680151
[TBL] [Abstract][Full Text] [Related]
3. Molecular detection of survivin expression, antiapoptotic gene, and other prognostic markers, how they are correlated and how it could be of prognostic value in chronic myeloid leukemia patient.
Zhara M; Mourad H; Farouk G; Elbatch M; Ezzat S; Sami W
Egypt J Immunol; 2007; 14(2):51-62. PubMed ID: 20306657
[TBL] [Abstract][Full Text] [Related]
4. [The expression and clinical significance of survivin gene in leukemia].
Wang Y; Lin FR; Ren JH; Zhang JN; Chen J
Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):628-30. PubMed ID: 17074144
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of wild type PTEN gene on Survivin, Xiap and Smac in chronic leukemia cells].
Cheng ZY; Wan JS; Wang YL; Liang LQ; Liang WT; Mu J; Lu X; Pan L
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2868-72. PubMed ID: 22333553
[TBL] [Abstract][Full Text] [Related]
6. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylation-mediated H19 overexpression increases the risk of disease evolution through the association with BCR-ABL transcript in chronic myeloid leukemia.
Zhou JD; Lin J; Zhang TJ; Ma JC; Li XX; Wen XM; Guo H; Xu ZJ; Deng ZQ; Zhang W; Qian J
J Cell Physiol; 2018 Mar; 233(3):2444-2450. PubMed ID: 28776669
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias.
Sugahara K; Uemura A; Harasawa H; Nagai H; Hirakata Y; Tomonaga M; Murata K; Sohda H; Nakagoe T; Shibasaki S; Yamada Y; Kamihira S
Int J Hematol; 2004 Jul; 80(1):52-8. PubMed ID: 15293568
[TBL] [Abstract][Full Text] [Related]
9. Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis: a sequential study in 42 patients.
Hernández-Boluda JC; Cervantes F; Colomer D; Vela MC; Costa D; Paz MF; Esteller M; Montserrat E
Exp Hematol; 2003 Mar; 31(3):204-10. PubMed ID: 12644017
[TBL] [Abstract][Full Text] [Related]
10. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
[TBL] [Abstract][Full Text] [Related]
11. [Expression of survivin gene in NB4 cell line and cells of acute promyelocytic leukemia and its anti-apoptosis and clinical significance].
Xue J; Lin MF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):332-6. PubMed ID: 16638209
[TBL] [Abstract][Full Text] [Related]
12. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
13. BAX/BCL-XL gene expression ratio inversely correlates with disease progression in chronic myeloid leukemia.
Gonzalez MS; De Brasi CD; Bianchini M; Gargallo P; Moiraghi B; Bengió R; Larripa IB
Blood Cells Mol Dis; 2010 Oct; 45(3):192-6. PubMed ID: 20728382
[TBL] [Abstract][Full Text] [Related]
14. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
15. Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells.
Wolanin K; Magalska A; Mosieniak G; Klinger R; McKenna S; Vejda S; Sikora E; Piwocka K
Mol Cancer Res; 2006 Jul; 4(7):457-69. PubMed ID: 16849521
[TBL] [Abstract][Full Text] [Related]
16. Survivin expression in chronic myeloid leukemia.
Conte E; Stagno F; Guglielmo P; Scuto A; Consoli C; Messina A
Cancer Lett; 2005 Jul; 225(1):105-10. PubMed ID: 15922862
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of quantitative assessment of JunB gene expression as a marker for monitoring chronic myeloid leukemia patients undergoing imatinib therapy.
Liu YC; Hsiao HH; Chang JG; Yang MY; Liu TC; Chang CS; Tseng SB; Tsai HJ; Lin SF
Int J Hematol; 2006 Dec; 84(5):425-31. PubMed ID: 17189224
[TBL] [Abstract][Full Text] [Related]
18. Expressions of cyclin E2 and survivin in acute leukemia and their correlation.
Wang Y; Xu SR; Lin FR; Guo XN; Ren JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):337-42. PubMed ID: 16638210
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
Wang Z; Sampath J; Fukuda S; Pelus LM
Cancer Res; 2005 Sep; 65(18):8224-32. PubMed ID: 16166298
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
